Susquehanna International Group, LLP Nu Cana PLC Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.26 - $0.42 $3,680 - $5,945	14,156 New	14,156 $3,000
Q4 2022 Feb 14, 2023	BUY	$0.66 - $27.41 $40,350 - $1.68 Million	61,137 New	61,137 $40,000
Q3 2019 Nov 14, 2019	SELL	$6.95 - $10.71 $93,130 - $143,514	-13,400 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$9.74 - $17.45 $262 - $471	27 Added 0.2%	13,400 $139,000
Q2 2019 Aug 14, 2019	BUY	$9.74 - $17.45 $130,253 - $233,358	13,373 New	13,373 $139,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $65.2M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.